Status | Study |
Recruiting |
Study Name: A Study of HTD1801 in Healthy Subjects Condition: Primary Sclerosing Cholangitis Date: 2017-03-14 Interventions: Drug: HTD1801 A small molecular compound for the treatment of primary sclerosing cholangitis |
Not yet recruiting |
Study Name: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma Condition: Bile Duct Cancer Intrahepatic Cholangiocarcinoma Date: 2017-03-13 Interventions: Combination Product: Melphalan/HDS |
Recruiting |
Study Name: Microbiomes in Patients of Recurrent Common Bile Duct Stones Condition: Cholelithiasis Choledocholithiasis Date: 2017-03-08 |
Recruiting |
Study Name: Antibiotics to Decrease Post ERCP Cholangitis Condition: Cholangitis Date: 2017-03-05 Interventions: Drug: Ceftriaxone Intravenous |
Available |
Study Name: Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease Condition: Cholestasis Liver Diseases Date: 2017-03-02 Interventions: Drug: Omegaven Omegaven™ will be initiated at 0.5 gm fat/kg of body weight per day (5cc/kg per day |
Recruiting |
Study Name: "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" Condition: Primary Sclerosing Cholangitis Autoimmune Hepatitis Overla Date: 2017-02-28 Interventions: Drug: Metronidazole or Vancomycine Flagyl or Vancomycine x 14 days. |
Completed |
Study Name: An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects Condition: Orphan Cholestatic Liver Diseases Progressive Familial Intrahepatic Cholestasis Date: 2017-02-27 Interventions: Drug: 3 mg [14C]-A4250 capsule Each subject will receive a single administration of 3 mg [14C]-A4250 cap |
Recruiting |
Study Name: Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP Condition: Choledocholithiasis Biliary Obstruction Date: 2017-02-23 Interventions: Procedure: Cholangioscopy Chol |
Completed |
Study Name: Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Cholangiocarcinoma Date: 2017-02-01 Interventions: Diagnostic Test: MR/MRCP MR/MRCP |
Recruiting |
Study Name: Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients Condition: Primary Sclerosing Cholangitis Post- Orthotopic Liver Transplantation Date: 2017-01-31 Interventions: Drug: Vancomycin Vancomycin belongs to the family of medicines called antibiotics.When taken by mouth, i |